Wall Street Rebounds as Tech Sector Stabilizes
15.12.2025 - 14:56:02Dow Jones US2605661048
Buyers have returned to U.S. markets at the start of the week, initiating a recovery following Friday's pronounced sell-off. A firming technology sector is providing the primary momentum, pointing to a positive opening session. The sustainability of this improved sentiment, however, faces a key test from impending inflation reports.
The early recovery is being supported by several factors beyond equities. A slight easing in bond yields is providing some relief for stock valuations. Specifically, the yield on the benchmark 10-year U.S. Treasury note has retreated to 4.17%. Furthermore, European indices, including the DAX and the Euro Stoxx 50, are trading higher, contributing positive momentum for the U.S. open.
Pre-market trading indicates a strong start for the Dow Jones Industrial Average. Futures for the blue-chip index are up 0.43% at 48,681 points, suggesting it will reclaim the 48,600 level at the opening bell. Market observers view this as a counter-move to Friday's losses, which were driven by concerns over a potential "AI bubble" that pulled the Nasdaq down by 1.7%.
Should investors sell immediately? Or is it worth buying Dow Jones?
Technology Shares Lead the Advance
Once again, technology stocks are at the forefront of market movements. The pre-market session shows notable activity among key players:
- NVIDIA (NVDA) is a significant driver, with shares gaining approximately 1.0% and lifting overall market sentiment. Reports of planned production increases for its H200 chips, fueled by strong demand from China, are helping to counter recent growth anxieties.
- Apple (AAPL) is trading modestly higher at $278.62, bolstered by positive analyst commentary regarding its holiday sales performance.
- Boeing (BA) is showing relative weakness, declining 0.45% before the bell. Ongoing delays in production certifications continue to weigh on the aerospace manufacturer's stock.
- Outside the Dow components, Argenx (ARGX) is under significant pressure. The biotech firm's shares have plunged more than 8% following the discontinuation of a clinical trial.
Technical Perspective and Critical Data Ahead
From a chart analysis standpoint, the Dow Jones remains in a consolidation phase near its record highs. A crucial support zone exists around the 48,000-point level, reinforced by the 50-day moving average at 48,053 points. Immediate resistance is seen at the all-time high near 48,880 points. A decisive breakout above this barrier would open a path toward the psychologically significant 50,000-point milestone.
The trajectory for the remainder of the week will likely be dictated by macroeconomic releases. Key catalysts are on the horizon, with retail sales data due Tuesday and the crucial Consumer Price Index (CPI) inflation report scheduled for Thursday. These figures will provide critical insight into the economic landscape and determine whether today's recovery has lasting power.
Ad
Dow Jones Stock: Buy or Sell?! New Dow Jones Analysis from December 15 delivers the answer:
The latest Dow Jones figures speak for themselves: Urgent action needed for Dow Jones investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 15.
Dow Jones: Buy or sell? Read more here...


